Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Total Current Liabilities (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Total Current Liabilities readings, the most recent being $242.7 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 1.75% to $242.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $242.7 million, a 1.75% decrease, with the full-year FY2025 number at $242.7 million, down 1.75% from a year prior.
  • Total Current Liabilities hit $242.7 million in Q4 2025 for Tandem Diabetes Care, down from $252.5 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $288.2 million in Q1 2025 to a low of $103.4 million in Q1 2021.
  • Median Total Current Liabilities over the past 5 years was $180.9 million (2023), compared with a mean of $188.8 million.
  • Biggest five-year swings in Total Current Liabilities: dropped 4.89% in 2021 and later skyrocketed 49.34% in 2025.
  • Tandem Diabetes Care's Total Current Liabilities stood at $131.9 million in 2021, then increased by 25.36% to $165.3 million in 2022, then increased by 18.13% to $195.3 million in 2023, then increased by 26.52% to $247.0 million in 2024, then dropped by 1.75% to $242.7 million in 2025.
  • The last three reported values for Total Current Liabilities were $242.7 million (Q4 2025), $252.5 million (Q3 2025), and $251.7 million (Q2 2025) per Business Quant data.